The Use of Hydroxyurea and Leukapheresis in Childhood Acute Leukemia With Hyperleukocytosis. J Pediatr Hematol Oncol. 2016..
Telemedicine in Pediatrics: A Systematic Review of Randomized Controlled Trials. JMIR Pediatr Parent. 2021..
Telemedicine in Malignant and Nonmalignant Hematology: Systematic Review of Pediatric and Adult Studies. JMIR Mhealth Uhealth. 2021;9(7):e29619..
Technology Use for Adolescent Health and Wellness. Pediatrics. 2020;145(Suppl 2):S186-S194..
Technology and Long-Term Health-Related Quality of Life Outcomes in Children with Nonmalignant Disorders Following RIC and SCT. Biol Blood Marrow Transplant. 2016..
Successful medical management of a neonate with spontaneous splenic rupture and severe hemophilia A. Hematol Oncol Stem Cell Ther. 2016..
A rare case of pancytopenia in a child with cystic fibrosis: Can copper cure it all?. Pediatr Pulmonol. 2021..
Post-Transplant cyclophosphamide is associated with increase in Non-CMV Herpesvirus infections in Acute leukemia and MDS patients. Transplant Cell Ther. 2021.
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T-cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research. Transplant Cell Ther. 2022.
Outcomes After Second Hematopoietic Cell Transplant for Children and Young Adults with Relapsed Acute Leukemia. Biol Blood Marrow Transplant. 2018.
Neonatal Compartment Syndrome Associated With Disseminated Intravascular Coagulation. Ann Plast Surg. 2015..
Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia. Blood Adv. 2020;4(6):983-992.
Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study. Blood Adv. 2020;4(18):4463-4473.
In-flight emergencies: Medical kits are not good enough for kids. J Paediatr Child Health. 2016;52(4):363-365..
The impact of pre-apheresis Health Related Quality of Life on peripheral blood progenitor cell yield and donor's health and outcome: Secondary analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials. Transplant Cell Ther. 2022.
Hydroxyurea Use After Transitions of Care Among Young Adults With Sickle Cell Disease and Tennessee Medicaid Insurance. JAMA Netw Open. 2021;4(10):e2128971..
Genetics of HLA peptide presentation, and impact on outcomes in HLA-matched allo-HCT. Transplant Cell Ther. 2021.
Empowering children and adolescents with sickle cell disease: a transition journey to adult care. Lancet Haematol. 2022;9(8):e562..
Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach. JMIR Mhealth Uhealth. 2020;8(5):e14884.
Chronic Graft-Versus-Host Disease, Non-Relapse Mortality and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A CIBMTR Analysis. Transplant Cell Ther. 2021.
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia. Blood Adv. 2019;3(20):3123-3131.
Association of Chronic Graft-versus-Host Disease with Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy. Transplant Cell Ther. 2022.
Association between clinical outcomes and metformin use in adults with sickle cell disease and diabetes mellitus. Blood Adv. 2019;3(21):3297-3306..
Applying the COM-B model to patient-reported barriers to medication adherence in pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2020:e28216.
Adherence to immunosuppression in adult heart transplant recipients: A systematic review. Transplant Rev (Orlando). 2021;35(4):100651..